[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-001", "question": "A 14-year-old boy with juvenile idiopathic arthritis presents with acute onset of fever, rash, and joint swelling after starting etanercept therapy. Laboratory findings include elevated ferritin, pancytopenia, and hypertriglyceridemia. What is the most appropriate next step in management?", "options": ["Discontinue etanercept and initiate high-dose corticosteroids", "Administer intravenous immunoglobulin", "Start rituximab infusion", "Perform bone marrow biopsy immediately", "Initiate broad-spectrum antibiotics"], "answer": "A", "answer_index": 0, "explanation": "This presentation is consistent with macrophage activation syndrome (MAS), a life-threatening complication in rheumatic diseases like juvenile idiopathic arthritis, often triggered by biologic agents such as etanercept. Discontinuing the offending agent and starting high-dose corticosteroids is the initial management to control the cytokine storm. Bone marrow biopsy may confirm hemophagocytosis but is not the immediate next step, and antibiotics are inappropriate without evidence of infection.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 14-year-old with juvenile idiopathic arthritis on etanercept; acute fever, rash, joint swelling; labs showing very high ferritin, pancytopenia, and hypertriglyceridemia. This constellation is classic for macrophage activation syndrome/secondary HLH in a JIA patient, often triggered by biologics. Standard initial management is to stop the triggering agent and start high-dose systemic corticosteroids.\\nOption analysis: A) Directly addresses presumed MAS by removing the suspected trigger (etanercept) and initiating first-line immunosuppression (high-dose steroids). B) IVIG is not first-line for MAS in JIA; may be adjunctive but less appropriate as initial step. C) Rituximab targets B cells and is not standard acute therapy for MAS. D) Bone marrow biopsy can help confirm hemophagocytosis but is diagnostic, not the immediate therapeutic priority. E) Broad-spectrum antibiotics are not indicated without infection evidence and would delay definitive treatment.\\nMain medical/logical issues: Item is slightly simplified (real-world management may include HLH-specific protocols), but the teaching point and key are consistent with board-level expectations.\\nMinimal fix: Specify “markedly elevated ferritin (>5000 ng/mL)” to further strengthen the MAS diagnosis context.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 14-year-old with juvenile idiopathic arthritis on etanercept; acute fever, rash, joint swelling; labs showing very high ferritin, pancytopenia, and hypertriglyceridemia. This constellation is classic for macrophage activation syndrome/secondary HLH in a JIA patient, often triggered by biologics. Standard initial management is to stop the triggering agent and start high-dose systemic corticosteroids.\nOption analysis: A) Directly addresses presumed MAS by removing the suspected trigger (etanercept) and initiating first-line immunosuppression (high-dose steroids). B) IVIG is not first-line for MAS in JIA; may be adjunctive but less appropriate as initial step. C) Rituximab targets B cells and is not standard acute therapy for MAS. D) Bone marrow biopsy can help confirm hemophagocytosis but is diagnostic, not the immediate therapeutic priority. E) Broad-spectrum antibiotics are not indicated without infection evidence and would delay definitive treatment.\nMain medical/logical issues: Item is slightly simplified (real-world management may include HLH-specific protocols), but the teaching point and key are consistent with board-level expectations.\nMinimal fix: Specify “markedly elevated ferritin (>5000 ng/mL)” to further strengthen the MAS diagnosis context.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-002", "question": "A 65-year-old man with hypertrophic cardiomyopathy develops sudden syncope during exercise. Echocardiography shows left ventricular outflow tract obstruction with a gradient of 80 mmHg. Despite beta-blocker therapy, symptoms persist. What is the most definitive management option?", "options": ["Surgical septal myectomy", "Alcohol septal ablation", "Implantable cardioverter-defibrillator placement", "Dual-chamber pacing", "Verapamil initiation"], "answer": "A", "answer_index": 0, "explanation": "Surgical septal myectomy is the gold standard for symptomatic hypertrophic cardiomyopathy with severe outflow tract obstruction refractory to medical therapy, offering superior long-term outcomes in experienced centers. Alcohol septal ablation is an alternative but carries risks like heart block and is less effective in younger patients. ICD placement addresses arrhythmic risk but not the obstruction itself.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 65-year-old man, hypertrophic cardiomyopathy, exertional syncope, LV outflow tract obstruction with high gradient (80 mmHg), persistent symptoms despite beta-blocker therapy. The question asks for the most definitive management of symptomatic obstructive HCM refractory to medical therapy. Current guidelines and standard teaching state that surgical septal myectomy is the gold standard for relieving LVOT obstruction in appropriate candidates, especially with severe gradients and limiting symptoms.\\n\\nOption A (surgical septal myectomy) directly addresses the obstruction and is guideline-preferred in suitable patients, making it the best definitive therapy. Option B (alcohol septal ablation) is an alternative for patients who are poor surgical candidates or older/frail; at 65 this might be considered, but myectomy remains the reference standard, so B is secondary. C (ICD) treats arrhythmic risk but not obstruction; not the definitive management of LVOT obstruction. D (dual-chamber pacing) has limited and inconsistent benefit in modern care. E (verapamil) is another negative inotrope, not definitive after beta-blocker failure with severe gradient.\\n\\nMinimal fix: Explicitly state that the patient is an acceptable surgical candidate to avoid any doubt about choosing myectomy over alcohol ablation.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 65-year-old man, hypertrophic cardiomyopathy, exertional syncope, LV outflow tract obstruction with high gradient (80 mmHg), persistent symptoms despite beta-blocker therapy. The question asks for the most definitive management of symptomatic obstructive HCM refractory to medical therapy. Current guidelines and standard teaching state that surgical septal myectomy is the gold standard for relieving LVOT obstruction in appropriate candidates, especially with severe gradients and limiting symptoms.\n\nOption A (surgical septal myectomy) directly addresses the obstruction and is guideline-preferred in suitable patients, making it the best definitive therapy. Option B (alcohol septal ablation) is an alternative for patients who are poor surgical candidates or older/frail; at 65 this might be considered, but myectomy remains the reference standard, so B is secondary. C (ICD) treats arrhythmic risk but not obstruction; not the definitive management of LVOT obstruction. D (dual-chamber pacing) has limited and inconsistent benefit in modern care. E (verapamil) is another negative inotrope, not definitive after beta-blocker failure with severe gradient.\n\nMinimal fix: Explicitly state that the patient is an acceptable surgical candidate to avoid any doubt about choosing myectomy over alcohol ablation.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-003", "question": "A term neonate develops respiratory distress and hypotension shortly after birth. Physical exam reveals hepatomegaly and poor perfusion. Echocardiogram shows dilated cardiomyopathy. Maternal history includes untreated systemic lupus erythematosus. What is the underlying mechanism?", "options": ["Transplacental passage of anti-Ro/SSA antibodies causing atrioventricular block", "Congenital viral infection leading to myocarditis", "Inborn error of metabolism affecting cardiac function", "Asphyxia-induced hypoxic cardiomyopathy", "Genetic mutation in sarcomeric proteins"], "answer": "A", "answer_index": 0, "explanation": "Neonatal lupus from maternal anti-Ro/SSA antibodies can cause complete heart block and cardiomyopathy, leading to heart failure in the newborn. This is distinct from viral myocarditis, which typically presents later and lacks the maternal autoimmune history. Metabolic or genetic causes are less likely without additional syndromic features.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed)\\nVerdict on keyed answer: Miskeyed\\n\\nKey stem clues: term neonate, immediate postnatal onset of respiratory distress and hypotension, hepatomegaly and poor perfusion, echocardiogram with dilated cardiomyopathy, maternal history of untreated SLE. Question asks for the underlying mechanism of this presentation.\\n\\nNeonatal lupus due to anti-Ro/SSA is classically associated with congenital complete heart block (fibrosis/calcification of AV node), mechanism: antibody-mediated injury to conduction tissue. That mechanism is best captured by “transplacental passage of anti-Ro/SSA antibodies causing atrioventricular block.” However, the vignette’s only cardiac finding is dilated cardiomyopathy; heart block, bradycardia, or conduction abnormality is not mentioned. Dilated cardiomyopathy per se could arise from viral myocarditis, inborn errors, hypoxia, or genetic causes; the stem does not provide discriminating data to make antibody-mediated AV block specifically the mechanism of the observed cardiomyopathy.\\n\\nThus a unique best answer cannot be defended from the given data, and matching the keyed option requires an unstated assumption (that heart block is present). Minimal fix: explicitly state fetal/neonatal bradycardia and ECG/echo evidence of complete AV block in the stem, or change the keyed option to an antibody-mediated myocardial injury mechanism that does not specify AV block.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed)\nVerdict on keyed answer: Miskeyed\n\nKey stem clues: term neonate, immediate postnatal onset of respiratory distress and hypotension, hepatomegaly and poor perfusion, echocardiogram with dilated cardiomyopathy, maternal history of untreated SLE. Question asks for the underlying mechanism of this presentation.\n\nNeonatal lupus due to anti-Ro/SSA is classically associated with congenital complete heart block (fibrosis/calcification of AV node), mechanism: antibody-mediated injury to conduction tissue. That mechanism is best captured by “transplacental passage of anti-Ro/SSA antibodies causing atrioventricular block.” However, the vignette’s only cardiac finding is dilated cardiomyopathy; heart block, bradycardia, or conduction abnormality is not mentioned. Dilated cardiomyopathy per se could arise from viral myocarditis, inborn errors, hypoxia, or genetic causes; the stem does not provide discriminating data to make antibody-mediated AV block specifically the mechanism of the observed cardiomyopathy.\n\nThus a unique best answer cannot be defended from the given data, and matching the keyed option requires an unstated assumption (that heart block is present). Minimal fix: explicitly state fetal/neonatal bradycardia and ECG/echo evidence of complete AV block in the stem, or change the keyed option to an antibody-mediated myocardial injury mechanism that does not specify AV block.\n", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-004", "question": "A 28-year-old woman at 32 weeks gestation presents with severe preeclampsia and acute dyspnea. Echocardiography reveals peripartum cardiomyopathy with ejection fraction of 30%. What is the most critical intervention to improve maternal outcomes?", "options": ["Immediate delivery via cesarean section", "Initiate bromocriptine to suppress prolactin", "Administer intravenous furosemide and vasodilators", "Start anticoagulation with low-molecular-weight heparin", "Perform urgent cardiac transplantation evaluation"], "answer": "B", "answer_index": 1, "explanation": "Bromocriptine inhibits prolactin, which is implicated in the pathogenesis of peripartum cardiomyopathy, and has shown benefit in improving left ventricular function when added to standard heart failure therapy. Immediate delivery may be necessary for preeclampsia but does not directly address cardiomyopathy. Diuretics and vasodilators manage symptoms but are not disease-modifying in this context.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (multiple defensible answers, possible miskey element)\\nVerdict on keyed answer: Not uniquely determinable; B is not clearly the single best or most critical intervention.\\nKey stem clues: 32 weeks gestation, severe preeclampsia, acute dyspnea, new peripartum cardiomyopathy with EF 30%. Question asks for “most critical intervention to improve maternal outcomes.”\\nLogical issues: In a 32‑week pregnancy with severe preeclampsia and maternal cardiac compromise, standard obstetric care prioritizes expeditious delivery as the definitive treatment to improve maternal outcomes; this strongly supports A. Bromocriptine is an adjunctive, not universally standard, disease‑modifying therapy for peripartum cardiomyopathy and is not the clearly “most critical” acute intervention, especially amid severe preeclampsia. Options C and D also have roles (acute decompensated HF management, thromboembolism prevention), further diluting the singularity of B. Thus more than one option—particularly A, C, and D—can be defended depending on whether the focus is acute stabilization vs long‑term LV recovery.\\nMedical accuracy: The pathophysiologic rationale for bromocriptine is accurate but somewhat overstated relative to guideline strength; labeling it the most critical measure is misleading.\\nMinimal fix: Reframe stem to a non-pregnant or postpartum patient with peripartum cardiomyopathy, or specify “disease‑modifying therapy for peripartum cardiomyopathy” to make B unambiguously best.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (multiple defensible answers, possible miskey element)\nVerdict on keyed answer: Not uniquely determinable; B is not clearly the single best or most critical intervention.\nKey stem clues: 32 weeks gestation, severe preeclampsia, acute dyspnea, new peripartum cardiomyopathy with EF 30%. Question asks for “most critical intervention to improve maternal outcomes.”\nLogical issues: In a 32‑week pregnancy with severe preeclampsia and maternal cardiac compromise, standard obstetric care prioritizes expeditious delivery as the definitive treatment to improve maternal outcomes; this strongly supports A. Bromocriptine is an adjunctive, not universally standard, disease‑modifying therapy for peripartum cardiomyopathy and is not the clearly “most critical” acute intervention, especially amid severe preeclampsia. Options C and D also have roles (acute decompensated HF management, thromboembolism prevention), further diluting the singularity of B. Thus more than one option—particularly A, C, and D—can be defended depending on whether the focus is acute stabilization vs long‑term LV recovery.\nMedical accuracy: The pathophysiologic rationale for bromocriptine is accurate but somewhat overstated relative to guideline strength; labeling it the most critical measure is misleading.\nMinimal fix: Reframe stem to a non-pregnant or postpartum patient with peripartum cardiomyopathy, or specify “disease‑modifying therapy for peripartum cardiomyopathy” to make B unambiguously best.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-005", "question": "In the ICU, a 55-year-old patient with septic shock on vasopressors develops acute kidney injury and metabolic acidosis. Despite fluid resuscitation, oliguria persists. Continuous renal replacement therapy is initiated. What is the most appropriate modality to optimize hemodynamic stability?", "options": ["Continuous venovenous hemodiafiltration with citrate anticoagulation", "Intermittent hemodialysis with bicarbonate buffer", "Sustained low-efficiency dialysis", "Peritoneal dialysis", "Continuous venovenous hemofiltration alone"], "answer": "A", "answer_index": 0, "explanation": "Continuous venovenous hemodiafiltration (CVVHDF) provides both convective and diffusive clearance, making it ideal for septic shock with acidosis, and citrate anticoagulation minimizes clotting while providing regional effects. Intermittent hemodialysis can cause hemodynamic instability in critically ill patients. Peritoneal dialysis is less efficient for rapid toxin removal in this setting.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: Septic shock, on vasopressors; acute kidney injury; metabolic acidosis; oliguria; goal is to “optimize hemodynamic stability”; CRRT initiated. Among options, all CRRT-type modalities (A, C, E) are more hemodynamically stable than intermittent HD. The stem does not prioritize solute clearance vs. pure hemodynamic tolerance.\\nMain logical issue(s): The question asks specifically about hemodynamic stability, not solute clearance or anticoagulation strategy. CVVH (E) and CVVHDF (A) are both CRRT and comparable for hemodynamic stability; the benefit of added diffusive clearance and citrate anticoagulation (A) relates more to solute control and anticoagulation than to hemodynamic stability per se. Thus at least A and E are similarly defensible for the asked endpoint. This makes the item a multiple-defensible-answer problem rather than a clean single-best.\\nMain medical accuracy issue(s): CVVHDF as a CRRT modality with regional citrate anticoagulation is appropriate and standard for septic shock with AKI; explanation is medically sound but misaligned with the narrow stem question.\\nMinimal fix: Reword stem to ask for “optimal modality for both hemodynamic stability and solute (acid) control and filter lifespan” or remove E and leave only one CRRT option.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: Septic shock, on vasopressors; acute kidney injury; metabolic acidosis; oliguria; goal is to “optimize hemodynamic stability”; CRRT initiated. Among options, all CRRT-type modalities (A, C, E) are more hemodynamically stable than intermittent HD. The stem does not prioritize solute clearance vs. pure hemodynamic tolerance.\nMain logical issue(s): The question asks specifically about hemodynamic stability, not solute clearance or anticoagulation strategy. CVVH (E) and CVVHDF (A) are both CRRT and comparable for hemodynamic stability; the benefit of added diffusive clearance and citrate anticoagulation (A) relates more to solute control and anticoagulation than to hemodynamic stability per se. Thus at least A and E are similarly defensible for the asked endpoint. This makes the item a multiple-defensible-answer problem rather than a clean single-best.\nMain medical accuracy issue(s): CVVHDF as a CRRT modality with regional citrate anticoagulation is appropriate and standard for septic shock with AKI; explanation is medically sound but misaligned with the narrow stem question.\nMinimal fix: Reword stem to ask for “optimal modality for both hemodynamic stability and solute (acid) control and filter lifespan” or remove E and leave only one CRRT option.\n", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-006", "question": "A 45-year-old woman with rheumatoid arthritis on methotrexate develops progressive dyspnea and dry cough. High-resolution CT shows subpleural reticular opacities and traction bronchiectasis. Pulmonary function tests reveal restrictive pattern. What is the most likely diagnosis?", "options": ["Methotrexate-induced interstitial lung disease", "Rheumatoid arthritis-associated usual interstitial pneumonia", "Hypersensitivity pneumonitis from environmental exposure", "Non-specific interstitial pneumonia", "Cryptogenic organizing pneumonia"], "answer": "B", "answer_index": 1, "explanation": "Rheumatoid arthritis can cause interstitial lung disease with a usual interstitial pneumonia pattern, which is more common than methotrexate toxicity in long-term users. Methotrexate-induced ILD typically presents acutely and improves upon discontinuation, unlike this progressive course. Hypersensitivity pneumonitis would show upper lobe predominance and different triggers.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 45-year-old woman with established rheumatoid arthritis on methotrexate; progressive (chronic) dyspnea and dry cough; HRCT with subpleural reticular opacities and traction bronchiectasis (a fibrotic, basal/subpleural pattern typical of UIP); restrictive PFTs. No mention of acute onset, fever, or new exposure history.\\n\\nThese features strongly support rheumatoid arthritis–associated usual interstitial pneumonia over methotrexate-induced ILD, which is classically acute/subacute, often with fever and hypersensitivity-type features and less specific UIP description. Hypersensitivity pneumonitis is usually upper/mid-lung predominant with exposure history and often centrilobular nodules/air trapping. NSIP is more homogeneous, often lacks classic subpleural honeycombing/traction bronchiectasis dominance. Cryptogenic organizing pneumonia presents with patchy consolidations rather than reticular fibrosis and traction bronchiectasis.\\n\\nNo major internal contradictions or need for unstated assumptions; the item supports a single best answer matching the key.\\n\\nMain medical accuracy issue(s): None significant; relative frequency of RA-UIP vs methotrexate ILD is correctly implied and clinical patterns are appropriate for exam level.\\n\\nMinimal fix: Explicitly note basal/subpleural predominance or mention absence of fever/acute onset to further distinguish from methotrexate-induced ILD, though not strictly necessary.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 45-year-old woman with established rheumatoid arthritis on methotrexate; progressive (chronic) dyspnea and dry cough; HRCT with subpleural reticular opacities and traction bronchiectasis (a fibrotic, basal/subpleural pattern typical of UIP); restrictive PFTs. No mention of acute onset, fever, or new exposure history.\n\nThese features strongly support rheumatoid arthritis–associated usual interstitial pneumonia over methotrexate-induced ILD, which is classically acute/subacute, often with fever and hypersensitivity-type features and less specific UIP description. Hypersensitivity pneumonitis is usually upper/mid-lung predominant with exposure history and often centrilobular nodules/air trapping. NSIP is more homogeneous, often lacks classic subpleural honeycombing/traction bronchiectasis dominance. Cryptogenic organizing pneumonia presents with patchy consolidations rather than reticular fibrosis and traction bronchiectasis.\n\nNo major internal contradictions or need for unstated assumptions; the item supports a single best answer matching the key.\n\nMain medical accuracy issue(s): None significant; relative frequency of RA-UIP vs methotrexate ILD is correctly implied and clinical patterns are appropriate for exam level.\n\nMinimal fix: Explicitly note basal/subpleural predominance or mention absence of fever/acute onset to further distinguish from methotrexate-induced ILD, though not strictly necessary.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-007", "question": "A 2-year-old child with hypoplastic left heart syndrome post-Norwood procedure presents with cyanosis and metabolic acidosis. Echocardiography shows right ventricular dysfunction and tricuspid regurgitation. What is the most appropriate pharmacologic intervention?", "options": ["Milrinone infusion for inotropic support", "Prostaglandin E1 to maintain ductal patency", "Sildenafil for pulmonary hypertension", "Digoxin for rate control", "Epinephrine bolus for hypotension"], "answer": "A", "answer_index": 0, "explanation": "Milrinone provides inotropic support and pulmonary vasodilation, crucial for right ventricular failure in single-ventricle physiology after Norwood. Prostaglandin E1 is used preoperatively but not post-Norwood. Sildenafil targets pulmonary hypertension but lacks the inotropic effect needed here.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 2-year-old with hypoplastic left heart syndrome after Norwood (single right ventricle providing systemic output), now cyanotic with metabolic acidosis, echo showing right ventricular dysfunction and tricuspid regurgitation. This describes low cardiac output/right ventricular failure in single-ventricle physiology needing both inotropy and afterload/pulmonary vascular resistance reduction.\\nMilrinone infusion (A) is the best option: it provides inotropy and lusitropy while reducing afterload and pulmonary vascular resistance, and is standard in post-Norwood low-output/right ventricular dysfunction. B (prostaglandin E1) is typically not needed late post-Norwood in a 2‑year‑old; maintaining ductal patency is not the issue. C (sildenafil) offers pulmonary vasodilation but no inotropic support, insufficient for overt RV dysfunction and shock. D (digoxin) is not first-line for acute decompensated single-ventricle failure and not for “rate control” in this vignette. E (epinephrine bolus) is not appropriate as a bolus in this setting; if catecholamines are needed, they are infused and may worsen afterload.\\nMain medical accuracy issues: Minor only; item is aligned with current post-Norwood management.\\nMinimal fix: Clarify “acute low cardiac output with systemic hypotension” in stem to emphasize shock physiology needing inotropic support.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 2-year-old with hypoplastic left heart syndrome after Norwood (single right ventricle providing systemic output), now cyanotic with metabolic acidosis, echo showing right ventricular dysfunction and tricuspid regurgitation. This describes low cardiac output/right ventricular failure in single-ventricle physiology needing both inotropy and afterload/pulmonary vascular resistance reduction.\nMilrinone infusion (A) is the best option: it provides inotropy and lusitropy while reducing afterload and pulmonary vascular resistance, and is standard in post-Norwood low-output/right ventricular dysfunction. B (prostaglandin E1) is typically not needed late post-Norwood in a 2‑year‑old; maintaining ductal patency is not the issue. C (sildenafil) offers pulmonary vasodilation but no inotropic support, insufficient for overt RV dysfunction and shock. D (digoxin) is not first-line for acute decompensated single-ventricle failure and not for “rate control” in this vignette. E (epinephrine bolus) is not appropriate as a bolus in this setting; if catecholamines are needed, they are infused and may worsen afterload.\nMain medical accuracy issues: Minor only; item is aligned with current post-Norwood management.\nMinimal fix: Clarify “acute low cardiac output with systemic hypotension” in stem to emphasize shock physiology needing inotropic support.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-008", "question": "A 70-year-old man with atrial fibrillation on anticoagulation develops acute chest pain and hypotension. Coronary angiography shows no obstructive disease, but left ventriculography reveals apical ballooning. What is the underlying pathophysiology?", "options": ["Catecholamine surge leading to transient myocardial stunning", "Spontaneous coronary artery dissection", "Myocarditis from viral infection", "Embolic occlusion of distal coronaries", "Vasospasm induced by ergonovine"], "answer": "A", "answer_index": 0, "explanation": "Takotsubo cardiomyopathy involves catecholamine-mediated myocardial stunning, mimicking acute coronary syndrome without angiographic abnormalities. Dissection would show vessel irregularities on angiography. Myocarditis typically presents with inflammatory markers and different ventricular patterns.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Elderly man with acute chest pain and hypotension; coronary angiography shows no obstructive disease; left ventriculography reveals apical ballooning. This triad is classic for Takotsubo (stress-induced) cardiomyopathy. The well-accepted mechanism is a catecholamine surge causing transient myocardial stunning, making option A the clearly best choice.\\nOther options: B) Spontaneous coronary artery dissection would produce angiographic abnormalities (flaps, luminal irregularities); stem explicitly notes no obstructive disease. C) Myocarditis usually has global or non–apical regional dysfunction and inflammatory/viral prodrome, not the specific apical ballooning pattern with clean coronaries. D) Embolic distal occlusion would usually produce focal infarcts and distal vessel cutoff on angiography, not normal coronaries with classic Takotsubo morphology. E) Ergonovine-induced vasospasm is a provocation test; vasospasm would be seen angiographically and requires that drug exposure, which is not described.\\nMain logical issues: None; stem is sufficient and discriminative. \\nMain medical accuracy issues: None significant; pathophysiology and differentials are correctly portrayed at board-exam level.\\nMinimal fix: Optionally add “after emotional or physical stress” to reinforce the Takotsubo context, though not required for validity.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Elderly man with acute chest pain and hypotension; coronary angiography shows no obstructive disease; left ventriculography reveals apical ballooning. This triad is classic for Takotsubo (stress-induced) cardiomyopathy. The well-accepted mechanism is a catecholamine surge causing transient myocardial stunning, making option A the clearly best choice.\nOther options: B) Spontaneous coronary artery dissection would produce angiographic abnormalities (flaps, luminal irregularities); stem explicitly notes no obstructive disease. C) Myocarditis usually has global or non–apical regional dysfunction and inflammatory/viral prodrome, not the specific apical ballooning pattern with clean coronaries. D) Embolic distal occlusion would usually produce focal infarcts and distal vessel cutoff on angiography, not normal coronaries with classic Takotsubo morphology. E) Ergonovine-induced vasospasm is a provocation test; vasospasm would be seen angiographically and requires that drug exposure, which is not described.\nMain logical issues: None; stem is sufficient and discriminative. \nMain medical accuracy issues: None significant; pathophysiology and differentials are correctly portrayed at board-exam level.\nMinimal fix: Optionally add “after emotional or physical stress” to reinforce the Takotsubo context, though not required for validity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-009", "question": "A 35-year-old pregnant woman at 28 weeks with antiphospholipid syndrome develops thrombocytopenia and elevated liver enzymes. Fetal monitoring shows growth restriction. What is the most appropriate management strategy?", "options": ["Low-dose aspirin and low-molecular-weight heparin continuation with close monitoring", "Immediate delivery to prevent maternal deterioration", "Plasmapheresis for antibody removal", "Intravenous immunoglobulin infusion", "Switch to unfractionated heparin"], "answer": "A", "answer_index": 0, "explanation": "In antiphospholipid syndrome during pregnancy, continuing low-dose aspirin and LMWH is standard to manage thrombotic risks and prevent complications like HELLP-like syndrome, with vigilant monitoring. Immediate delivery is premature at 28 weeks without severe features. IVIG is not first-line and reserved for refractory cases.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N\\nVerdict on keyed answer: No defensible answer\\nKey stem clues: 35-year-old at 28 weeks, known antiphospholipid syndrome, now with thrombocytopenia, elevated liver enzymes, and fetal growth restriction. These findings suggest a HELLP-like or severe preeclampsia picture rather than stable APS. In that context, continuing current APS prophylaxis (aspirin + LMWH) alone is inadequate.\\nMain logical issues: The vignette describes potential severe maternal disease with end-organ involvement and compromised fetus at 28 weeks. Standard management for HELLP/severe preeclampsia after fetal viability focuses on maternal stabilization and usually delivery; none of the provided options explicitly state appropriate preeclampsia/HELLP management. Option A (keyed) ignores new severe features and does not address preeclampsia management, so it is not defensible as “most appropriate.” Options B–E also do not fully match guideline-based care, leaving no clearly correct best answer.\\nMain medical accuracy issues: Explanation oversimplifies APS pregnancy care and misrepresents thrombocytopenia + elevated LFTs as something managed solely by continuing APS prophylaxis.\\nMinimal fix: Clarify that laboratory abnormalities are mild, blood pressure and urine protein are normal, and there are no features of preeclampsia/HELLP, so the scenario is isolated APS in pregnancy where continuation of aspirin + LMWH with monitoring is appropriate; or instead change the answer/key to a delivery-focused option and rewrite choices accordingly.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N\nVerdict on keyed answer: No defensible answer\nKey stem clues: 35-year-old at 28 weeks, known antiphospholipid syndrome, now with thrombocytopenia, elevated liver enzymes, and fetal growth restriction. These findings suggest a HELLP-like or severe preeclampsia picture rather than stable APS. In that context, continuing current APS prophylaxis (aspirin + LMWH) alone is inadequate.\nMain logical issues: The vignette describes potential severe maternal disease with end-organ involvement and compromised fetus at 28 weeks. Standard management for HELLP/severe preeclampsia after fetal viability focuses on maternal stabilization and usually delivery; none of the provided options explicitly state appropriate preeclampsia/HELLP management. Option A (keyed) ignores new severe features and does not address preeclampsia management, so it is not defensible as “most appropriate.” Options B–E also do not fully match guideline-based care, leaving no clearly correct best answer.\nMain medical accuracy issues: Explanation oversimplifies APS pregnancy care and misrepresents thrombocytopenia + elevated LFTs as something managed solely by continuing APS prophylaxis.\nMinimal fix: Clarify that laboratory abnormalities are mild, blood pressure and urine protein are normal, and there are no features of preeclampsia/HELLP, so the scenario is isolated APS in pregnancy where continuation of aspirin + LMWH with monitoring is appropriate; or instead change the answer/key to a delivery-focused option and rewrite choices accordingly.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed126", "question_id": "20251201T041413890Z_grok-4-0709_seed126-010", "question": "In the critical care unit, a 60-year-old patient with acute respiratory distress syndrome on mechanical ventilation develops refractory hypoxemia despite prone positioning. Extracorporeal membrane oxygenation is considered. What is the primary indication for venovenous ECMO in this scenario?", "options": ["PaO2/FiO2 ratio less than 80 with FiO2 greater than 90%", "Hypercapnia unresponsive to increased minute ventilation", "Right ventricular failure on echocardiography", "Sepsis-induced myocardial depression", "Barotrauma from high plateau pressures"], "answer": "A", "answer_index": 0, "explanation": "Venovenous ECMO is indicated for severe ARDS when PaO2/FiO2 <80 on FiO2 >90%, despite optimal ventilatory support, to provide gas exchange. Hypercapnia alone may be managed with permissive strategies or ECCO2R. Right ventricular failure would prompt venoarterial ECMO consideration instead.", "generator_model": "grok-4-0709", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 60-year-old in ICU with severe ARDS on mechanical ventilation, refractory hypoxemia despite prone positioning, considering ECMO. The question asks for the primary indication for venovenous (VV) ECMO in this context. Option A (PaO2/FiO2 <80 with FiO2 >90%) directly reflects widely accepted VV-ECMO criteria in severe ARDS after optimal conventional management (including proning), serving as the classic hypoxemic indication.\\nOther options: B (isolated hypercapnia) is not a primary indication for VV-ECMO; usually managed with lung-protective ventilation, permissive hypercapnia, or ECCO2 removal. C (right ventricular failure) would favor venoarterial (VA) ECMO rather than VV. D (sepsis-induced myocardial depression) is also principally a VA-ECMO indication. E (barotrauma from high plateau pressures) is a consequence of injurious ventilation; while ECMO can help prevent further barotrauma by allowing ultra–low tidal volume/airway pressure, barotrauma itself is not the standard primary criterion, making A clearly superior.\\nMain medical accuracy issues: None significant; criteria and differentiation VV vs VA ECMO are consistent with standard guidance.\\nMinimal fix: Explicitly state that other lung-protective strategies (e.g., neuromuscular blockade, optimal PEEP) have been optimized to fully support the ECMO decision context.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 60-year-old in ICU with severe ARDS on mechanical ventilation, refractory hypoxemia despite prone positioning, considering ECMO. The question asks for the primary indication for venovenous (VV) ECMO in this context. Option A (PaO2/FiO2 <80 with FiO2 >90%) directly reflects widely accepted VV-ECMO criteria in severe ARDS after optimal conventional management (including proning), serving as the classic hypoxemic indication.\nOther options: B (isolated hypercapnia) is not a primary indication for VV-ECMO; usually managed with lung-protective ventilation, permissive hypercapnia, or ECCO2 removal. C (right ventricular failure) would favor venoarterial (VA) ECMO rather than VV. D (sepsis-induced myocardial depression) is also principally a VA-ECMO indication. E (barotrauma from high plateau pressures) is a consequence of injurious ventilation; while ECMO can help prevent further barotrauma by allowing ultra–low tidal volume/airway pressure, barotrauma itself is not the standard primary criterion, making A clearly superior.\nMain medical accuracy issues: None significant; criteria and differentiation VV vs VA ECMO are consistent with standard guidance.\nMinimal fix: Explicitly state that other lung-protective strategies (e.g., neuromuscular blockade, optimal PEEP) have been optimized to fully support the ECMO decision context.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]